Information on the Target

ORA, a Singapore-based telehealth platform founded by Elias Pour, is revolutionizing the healthcare experience by focusing on a vertically-integrated model. Launched in 2021, ORA operates through three distinct brands: Modules, which provides dermatological services; andSons, catering to men's health; and OVA, offering reproductive healthcare for women. This innovative approach integrates digital consultations with physical services, enabling ORA to offer comprehensive healthcare solutions.

Since its inception, ORA has achieved substantial growth, having conducted over 250,000 consultations, with a continuously expanding customer base. The company's model emphasizes vertical integration, allowing it to maintain control over healthcare quality and services, which is particularly vital given the rising costs associated with pharmacies. ORA is set to enhance its market presence by making its products available in 1,300 retail stores later this year.

Industry Overview in Southeast Asia

The healthcare sector in Southeast Asia is undergoing a paradigm shift fueled by increasing demand for digital health solutions. The region has seen a significant rise in health-conscious consumers, particularly among the younger demographic, who are increasingly prioritizing health and wellness. With around 40% of healthcare expenditures coming directly from consumers, there exists a vast opportunity for innovative healthcare platforms such as ORA.

In addition, the affluent middle-class population is rapidly growing, contributing to an upward pressure on healthcare services and costs. As out-of-pocket expenses for healthcare continue to rise, consumers are more inclined to seek alternative solutions that provide value and quality care. This creates a favorable environment for vertically-integrated health platforms.

The focus on chronic conditions instead of episodic treatment is another critical factor influencing the industry. Approximately 70% of ORA's revenue is derived from recurring subscriptions, indicating a strong customer retention strategy that appeals to the needs of patients seeking ongoing care.

Moreover, the COVID-19 pandemic has accelerated the acceptance of digital health services, prompting greater investment in telehealth solutions. This trend is becoming even more apparent in the Gulf Cooperation Council (GCC) countries, which are seen as potential target markets for ORA's expansion due to similar consumer spending behaviors on healthcare.

The Rationale Behind the Deal

The recent $10 million Series A funding round is critical for ORA's plans to expand both geographically and into new service areas, including weight management. With this funding, ORA has raised over $17 million to date, positioning itself to capitalize on its early-mover advantage in the telehealth sector. The investment will specifically facilitate enhancements to the platform and bolster the company's capabilities in delivering specialized health services.

Investors recognize ORA's potential to fill a significant gap in the healthcare market in Southeast Asia, a region where traditional healthcare systems often struggle to meet the needs of consumers. A robust infusion of capital will allow ORA to innovate further and solidify its footprint in the market.

Information About the Investor

The Series A round was led by TNB Aura and Antler, alongside participation from Gobi Partners, Kairous Capital, and GMA Ventures. TNB Aura's Founding Partner, Charles Wong, emphasizes ORA's unique positioning in specializing in taboo healthcare verticals. He views the company as poised for rapid growth due to its direct-to-patient model.

Additionally, Teddy Himler, a Global Partner at Antler, commented on the significant under-served population in Southeast Asia and the GCC, reinforcing the notion that ORA's platform represents the future of direct-to-patient healthcare on a global scale. This collective insight from knowledgeable investors showcases a growing confidence in ORA’s market approach.

View of Dealert

In evaluating ORA's recent investment round, it appears to be a sound opportunity that presents both high growth potential and sustainability within the healthcare sector. The company's strategy of vertical integration and focus on managing chronic health conditions indicates a long-term commitment to transforming patient care and experiences.

The aspect of recurring revenue from subscription plans also positions ORA favorably, allowing for predictable income streams which are essential for startups navigating market volatility. Higher retention rates compared to well-established brands like Netflix further demonstrate ORA's ability to engage and retain customers effectively.

Moreover, ORA's intent to expand geographically into markets with similar healthcare expenditure patterns, such as the GCC, provides a strategic pathway for growth that could substantially increase its customer base and service offerings.

Considering the current trends in healthcare consumption and technology adoption, ORA is likely to thrive and capture market share as a leader in the telehealth arena. The integration of digital solutions with physical healthcare services creates a holistic patient experience that is increasingly demanded in today's market.

View Original Article

Similar Deals

TKS I OBVIOHEALTH

2023

Series A Healthcare Providers & Services Singapore
GEC–KIP Technology and Innovation Fund WhiteCoat

2023

Series A Healthcare Providers & Services Singapore
Sony Group Corporation Impact Guru

2021

Series A Healthcare Providers & Services Singapore
BXR Group WonderSmile

2021

Series A Healthcare Providers & Services Singapore
Unitus Impact mClinica

2017

Series A Healthcare Providers & Services Singapore
Plural Teton.ai

2025

Series A Healthcare Providers & Services United States of America
Five Elms Capital Motivity

2025

Series A Healthcare Providers & Services United States of America
True Sava

2025

Series A Healthcare Providers & Services United States of America

TNB Aura and Antler

invested in

ORA

in 2023

in a Series A deal

Disclosed details

Transaction Size: $10M

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert